MedTrace Logo

Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy

NCT06596200 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-09-19

No results posted yet for this study

Summary

Spinal Cord Stimulation using 10 kHz stimulation to the thoracic spinal cord will be a safe and effective treatment for CIPN, reducing pain in the lower extremities by at least 50%.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Interventions

DEVICE

Spinal Cord Stimulation Implant

Spinal Cord Stimulation using 10 kHz stimulation to the thoracic spinal cord

Sponsors & Collaborators

  • University of Maryland St. Joseph Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-15
Primary Completion
2025-11-15
Completion
2026-11-15
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06596200 on ClinicalTrials.gov